Portable point-of-care blood tests, done by EMS before hospital arrival, need validation but could guide treatment and ...

IRVINE, Calif. - Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, has announced a funding round led by ...

Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its ...

Pearl Diagnostics will receive $1 million to evaluate the potential of a prototype assay for early detection of pneumonia caused by Pseudomonas aeruginosa.

Roche announced its next generation assay received FDA 510(k) clearance for the measurement of lipoprotein(a) for assessment ...

Altona reports assay results with 88.03% CaF2 from Monte Muambe. Company advances studies for efficient fluorspar production.